SANA
SANA BIOTECHNOLOGY INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
SANA BIOTECHNOLOGY INC (SANA) is held as common stock by 6 tracked hedge-fund managers, with a combined reported value of ~$10.61M; the largest are Renaissance Technologies, Izzy Englander, Steven Cohen. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 4 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders61 also report options
Congress trades0
Price$2.91vs quarter-end-16.62%
Sectors0
This quarter's moves
Top holderNew1
Added0
Trimmed / sold4
Renaissance TechnologiesCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Value $1.08M0.0% of portfolio310,4832026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Baker Bros. Advisors | $1.08M | 0.0% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $380.4K— of portfolio109,0002026 Q2
Value $250.2K— of portfolio71,7002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $380.4K | — | — |
| Ken GriffinPUT | $250.2K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.